It's obviously a very important issue. I think we have all been working very closely together with the Province of Ontario, with provincial officials, and with the Ontario College of Pharmacists to address the situation.
We understand there's a situation in which compounds that were—or in some cases still are—mixed in the hospital pharmacy for chemotherapy have, in the case of these particular hospitals, moved outside the hospital through a contract to an outside company. We are working very closely with Ontario to understand what is happening and to assure ourselves, and obviously Ontario, that we are providing whatever assistance we can to them to make sure there is proper oversight of this situation.
It is a changing and evolving one, as we are learning. That's why we are working closely with our partners in Ontario. We will obviously want to work across the country as well.